[HTML][HTML] The health equity in all policies (HEiAP) approach before and beyond the Covid-19 pandemic in the Italian context
R Bucciardini, B Contoli, P De Castro… - International Journal for …, 2020 - Springer
For years, the scientific community has tried to promote the approach of Health Equity in All
Policies (HEiAP) to policy decision-makers without having received an effective response …
Policies (HEiAP) to policy decision-makers without having received an effective response …
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as …
…, B Autran, A Antinori, R Bucciardini… - Journal of …, 2016 - academic.oup.com
Objectives To describe the pattern of drug resistance at virological failure in the NEAT001/ANRS143
trial (first-line treatment with ritonavir-boosted darunavir plus either tenofovir/…
trial (first-line treatment with ritonavir-boosted darunavir plus either tenofovir/…
[HTML][HTML] Retention in care of adult HIV patients initiating antiretroviral therapy in Tigray, Ethiopia: a prospective observational cohort study
R Bucciardini, V Fragola, T Abegaz, S Lucattini… - PloS one, 2015 - journals.plos.org
Introduction Although Ethiopia has been scaling up the antiretroviral therapy (ART) services,
low retention in care of patients remains one of the main obstacles to treatment success. We …
low retention in care of patients remains one of the main obstacles to treatment success. We …
[HTML][HTML] Addressing health inequalities in Europe: key messages from the Joint Action Health Equity Europe (JAHEE)
R Bucciardini, P Zetterquist, T Rotko, V Putatti… - Archives of Public …, 2023 - Springer
Health inequalities within and between Member States of the European Union are widely
recognized as a public health problem as they determine a significant share of potentially …
recognized as a public health problem as they determine a significant share of potentially …
Residual viraemia in subjects with chronic HIV infection and viral load< 50 copies/ml: the impact of highly active antiretroviral therapy
…, MF Pirillo, M Andreotti, CM Galluzzo, R Bucciardini… - Aids, 2005 - journals.lww.com
Objective: To determine factors associated with< 2.5 copies/ml plasma HIV RNA in subjects
treated with highly active antiretroviral therapy (HAART) and with viraemia< 50 copies/ml. …
treated with highly active antiretroviral therapy (HAART) and with viraemia< 50 copies/ml. …
Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients
R Bucciardini, K Pugliese, L Weimer… - HIV clinical …, 2014 - Taylor & Francis
Background: Health-related quality of life (HRQoL) has been recognized as a central measure
of the overall health status in HIV patients. With the availability of different highly effective …
of the overall health status in HIV patients. With the availability of different highly effective …
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita …
L Palmisano, M Giuliano, R Bucciardini… - JAIDS Journal of …, 2007 - journals.lww.com
Background: Factors influencing the outcome of structured treatment interruptions (STIs) in
HIV chronic infection are not fully elucidated. Methods: In ISS-PART, 273 subjects were …
HIV chronic infection are not fully elucidated. Methods: In ISS-PART, 273 subjects were …
[HTML][HTML] Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in Tigray, Ethiopia
R Bucciardini, V Fragola, T Abegaz, S Lucattini… - BMJ global …, 2017 - gh.bmj.com
Introduction Ethiopia has experienced rapid expansion of antiretroviral therapy (ART).
However, as long-term retention in ART therapy is key for ART effectiveness, determinants of …
However, as long-term retention in ART therapy is key for ART effectiveness, determinants of …
ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era
Objective: To design a Health-related Quality of Life (HRQoL) instrument for HIV-infected
people in the era of highly active antiretroviral therapy (HAART). Methods: The self-…
people in the era of highly active antiretroviral therapy (HAART). Methods: The self-…
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive …
M Floridia, R Bucciardini, D Ricciardulli… - JAIDS Journal of …, 1999 - journals.lww.com
The immunologic and virologic activity of nevirapine in combination with two nucleosides (zidovudine
[ZDV] and didanosine [ddI]) was evaluated in antiretroviral-naive patients with a …
[ZDV] and didanosine [ddI]) was evaluated in antiretroviral-naive patients with a …